Trials / Completed
CompletedNCT04593095
Nurturing and Quiet Intervention: NeuroN-QI
Nurturing and Quiet Intervention (NeuroN-QI) on Preterm Infants' Neurodevelopment and Maternal Stress and Anxiety: Protocol of a Pilot Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- St. Justine's Hospital · Academic / Other
- Sex
- All
- Age
- 26 Weeks – 32 Weeks
- Healthy volunteers
- Accepted
Summary
The current state of knowledge reveals that the development of the brain of preterm infants is influenced by specific neonatal experiences during hospitalization, such as environmental sensory stimulation (light and noise), as well as physical and emotional proximity to mothers. However, there is a lack of evidence regarding the benefits that could be associated with the combination of care interventions to improve the health outcomes of preterm infants and their mothers, and in particular the development of the brain of infants during their hospitalization in the neonatal unit. The aim of this pilot study is to assess the feasibility and acceptability of a developmental care intervention including periods of nurturing between mothers and their infant (skin-to-skin contact and auditory stimulation) to promote physical and emotional proximity and a quiet period (controlled light and noise levels and olfactory stimulation in incubators) and to estimate the effect of this intervention on infants' neurodevelopment as well as on maternal stress and anxiety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NeuroN-QI | SSC session lasting 2-hr during the day 4 times/wk including a 15-min of auditory stimulation with maternal voice and controlled levels of NICU light and noise followed by a 1-hr quiet period where infants will rest in their incubator/crib with olfactory stimulation and where the control of light and noise levels will be continued. |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2020-10-19
- Last updated
- 2025-03-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04593095. Inclusion in this directory is not an endorsement.